Clinical Trials List
2024-01-01 - 2028-12-31
Others
Recruiting8
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Wen-Chi Shen 無
- Wen-Ling Kuo 無
- 沈士哲 無
- 張潤忠 無
- Chan-Keng Yang 無
- 周旭桓 無
- Mengting Peng 無
- 何蕙余 Division of General Surgery
- Yung-Chang Lin 無
- Chi-Chang Yu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林昶廷 無
- 陳彥豪 無
- 李易濰 無
- 陳彥仰 無
- 吳佳哲 無
- Tai-Jan Chiu 無
- 黃詩喻 無
- Shau-Hsuan Li 無
- 郭明濬 無
- Yu-Li Su 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Hui Lee 無
- Jui-Hung Tsai 無
- 楊舜如 無
- Kuo-Ting Lee 無
- Zhu-Jun Loh 無
- 黃怡菁 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 巫承哲 無
- 高捷妮 無
- Junping Shiau Shiau 無
- 甘蓉瑜 無
- Shen Liang Shih 無
- Fang-Ming Chen 無
- Chung-Liang Li 無
- 高理鈞 無
- Chieh-Han Chuang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- HSIN-CHEN LIN 無
- Huey-En Tzeng 無
- ZHENG-WEI ZHOU 無
- 陳維信 無
- I-Chen Tsai 無
- 王國鐘 無
- 林慈恩 無
- 楊陽生 無
- Kuan-Der Lee 無
- 劉佳樺 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃至豪 無
- Chih-Jung Chen 無
- Chen-Teng Wu 無
- Liang-Chih Liu 無
- Yao-Chung Wu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
45 participants
-
Global
794 participants
